Lineage Cell Therapeutics, Inc. Operating Cash Flow
Lineage Cell Therapeutics, Inc. (LCTX) reported Operating Cash Flow of -$15.32 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- Lineage Cell Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$7.24M.
- Lineage Cell Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$8.08M.
- Lineage Cell Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$4.88M.
- Lineage Cell Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.62M.
- Lineage Cell Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$18.92M.
- Lineage Cell Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$23.09M.
- Lineage Cell Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$28.57M, a 2797.45% decline from fiscal 2022.
- Lineage Cell Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was $1.06M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$7.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$15.32M 10-Q · filed 2026-08-06 | -$20.20M derived: sum of 3 quarters · filed 2026-08-06 | -$23.82M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$8.08M 10-Q · filed 2026-05-12 | -$12.96M derived: sum of 2 quarters · filed 2026-05-12 | -$16.57M derived: sum of 3 quarters · filed 2026-05-12 | -$22.11M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | -$4.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$8.49M derived: sum of 2 quarters · filed 2026-03-05 | -$14.03M derived: sum of 3 quarters · filed 2026-08-06 | -$18.92M 10-K · filed 2026-03-05 | ||
| 2025-09-30 | -$3.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$9.15M derived: sum of 2 quarters · filed 2026-08-06 | -$14.04M 10-Q · filed 2025-11-06 | -$20.39M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | -$5.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$10.43M 10-Q · filed 2026-08-06 | -$16.77M derived: sum of 3 quarters · filed 2026-08-06 | -$22.56M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | -$4.89M 10-Q · filed 2026-05-12 | -$11.23M derived: sum of 2 quarters · filed 2026-05-12 | -$17.02M derived: sum of 3 quarters · filed 2026-05-12 | -$22.20M derived: sum of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | -$6.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$12.13M derived: sum of 2 quarters · filed 2026-03-05 | -$17.31M derived: sum of 3 quarters · filed 2026-03-05 | -$23.09M 10-K · filed 2026-03-05 | ||
| 2024-09-30 | -$5.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$10.96M derived: sum of 2 quarters · filed 2025-11-06 | -$16.75M 10-Q · filed 2025-11-06 | -$22.77M derived: sum of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | -$5.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$10.96M 10-Q · filed 2025-08-12 | -$16.98M derived: sum of 3 quarters · filed 2025-08-12 | -$22.02M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | -$5.78M 10-Q · filed 2025-05-13 | -$11.80M derived: sum of 2 quarters · filed 2025-05-13 | -$16.84M derived: sum of 3 quarters · filed 2025-05-13 | -$23.11M derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | -$6.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | -$11.06M derived: sum of 2 quarters · filed 2025-03-10 | -$17.32M derived: sum of 3 quarters · filed 2025-03-10 | -$28.57M 10-K · filed 2025-03-10 | ||
| 2023-09-30 | -$5.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$11.30M derived: sum of 2 quarters · filed 2024-11-14 | -$22.55M 10-Q · filed 2024-11-14 | -$30.85M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$6.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$17.51M 10-Q · filed 2024-08-08 | -$25.81M derived: sum of 3 quarters · filed 2024-08-08 | -$31.29M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | -$11.24M 10-Q · filed 2024-05-09 | -$19.55M derived: sum of 2 quarters · filed 2024-05-09 | -$25.02M derived: sum of 3 quarters · filed 2024-05-09 | -$32.09M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | -$8.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$13.78M derived: sum of 2 quarters · filed 2024-03-07 | -$20.84M derived: sum of 3 quarters · filed 2024-03-07 | $1.06M 10-K · filed 2024-03-07 | ||
| 2022-09-30 | -$5.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$12.54M derived: sum of 2 quarters · filed 2023-11-09 | $9.36M 10-Q · filed 2023-11-09 | $3.49M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | -$7.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $14.84M 10-Q · filed 2023-08-10 | $8.97M derived: sum of 3 quarters · filed 2023-08-10 | $4.12M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $21.90M 10-Q · filed 2023-05-11 | $16.03M derived: sum of 2 quarters · filed 2023-05-11 | $11.18M derived: sum of 3 quarters · filed 2023-05-11 | $5.77M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$5.87M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$10.72M derived: sum of 2 quarters · filed 2023-03-09 | -$16.14M derived: sum of 3 quarters · filed 2023-03-09 | -$23.56M 10-K · filed 2023-03-09 | ||
| 2021-09-30 | -$4.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$10.26M derived: sum of 2 quarters · filed 2022-11-10 | -$17.69M 10-Q · filed 2022-11-10 | -$23.33M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | -$5.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$12.84M 10-Q · filed 2022-08-11 | -$18.48M derived: sum of 3 quarters · filed 2022-08-11 | -$23.33M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | -$7.42M 10-Q · filed 2022-05-12 | -$13.06M derived: sum of 2 quarters · filed 2022-05-12 | -$17.91M derived: sum of 3 quarters · filed 2022-05-12 | -$22.15M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$5.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$10.49M derived: sum of 2 quarters · filed 2022-03-10 | -$14.73M derived: sum of 3 quarters · filed 2022-03-10 | -$19.75M 10-K · filed 2022-03-10 | ||
| 2020-09-30 | -$4.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$9.09M derived: sum of 2 quarters · filed 2021-11-10 | -$14.11M 10-Q · filed 2021-11-10 | -$19.64M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | -$4.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$9.27M 10-Q · filed 2021-08-12 | -$14.79M derived: sum of 3 quarters · filed 2021-08-12 | -$22.23M derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | -$5.03M 10-Q · filed 2021-05-13 | -$10.55M derived: sum of 2 quarters · filed 2021-05-13 | -$17.99M derived: sum of 3 quarters · filed 2021-05-13 | -$27.66M derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | -$5.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$12.97M derived: sum of 2 quarters · filed 2021-03-11 | -$22.63M derived: sum of 3 quarters · filed 2021-03-11 | -$31.95M 10-K · filed 2021-03-11 | ||
| 2019-09-30 | -$7.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$17.11M derived: sum of 2 quarters · filed 2020-11-04 | -$26.42M 10-Q · filed 2020-11-04 | -$32.24M derived: sum of 4 quarters · filed 2020-11-04 | ||
| 2019-06-30 | -$9.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$18.98M 10-Q · filed 2020-08-06 | -$24.79M derived: sum of 3 quarters · filed 2020-08-06 | -$32.13M derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | -$9.31M 10-Q · filed 2020-05-07 | -$15.13M derived: sum of 2 quarters · filed 2020-05-07 | -$22.46M derived: sum of 3 quarters · filed 2020-05-07 | -$29.86M derived: sum of 4 quarters · filed 2020-05-07 | ||
| 2018-12-31 | -$5.81M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$13.14M derived: sum of 2 quarters · filed 2020-03-12 | -$20.54M derived: sum of 3 quarters · filed 2020-03-12 | -$30.88M 10-K · filed 2020-03-12 | ||
| 2018-09-30 | -$7.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$14.73M derived: sum of 2 quarters · filed 2019-11-12 | -$25.07M 10-Q · filed 2019-11-12 | -$30.75M derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | -$7.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$17.74M 10-Q · filed 2019-08-08 | -$23.41M derived: sum of 3 quarters · filed 2019-08-08 | -$31.09M derived: sum of 4 quarters · filed 2019-08-08 | ||
| 2018-03-31 | -$10.34M 10-Q · filed 2019-05-09 | -$16.01M derived: sum of 2 quarters · filed 2019-05-09 | -$23.69M derived: sum of 3 quarters · filed 2019-05-09 | -$32.76M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2017-12-31 | -$5.67M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$13.36M derived: sum of 2 quarters · filed 2019-03-14 | -$22.42M derived: sum of 3 quarters · filed 2019-03-14 | -$30.52M 10-K · filed 2019-03-14 | ||
| 2017-09-30 | -$7.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$16.74M derived: sum of 2 quarters · filed 2018-11-08 | -$24.84M 10-Q · filed 2018-11-08 | -$33.69M derived: sum of 4 quarters · filed 2018-11-08 | ||
| 2017-06-30 | -$9.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$17.16M 10-Q · filed 2018-08-02 | -$26.01M derived: sum of 3 quarters · filed 2018-08-02 | -$34.93M derived: sum of 4 quarters · filed 2018-08-02 | ||
| 2017-03-31 | -$8.10M 10-Q · filed 2018-05-10 | -$16.95M derived: sum of 2 quarters · filed 2018-05-10 | -$25.86M derived: sum of 3 quarters · filed 2018-05-10 | |||
| 2016-12-31 | -$8.85M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$17.77M derived: sum of 2 quarters · filed 2018-03-15 | -$42.33M 10-K · filed 2018-03-15 | |||
| 2016-09-30 | -$8.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$33.47M 10-Q · filed 2017-11-09 | ||||
| 2016-06-30 | -$24.56M 10-Q · filed 2017-08-09 | |||||
| 2015-12-31 | -$44.54M 10-K · filed 2018-03-15 | |||||
| 2014-03-31 | -$10.36M 10-Q · filed 2014-05-12 | -$18.98M derived: sum of 2 quarters · filed 2014-05-12 | -$25.40M derived: sum of 3 quarters · filed 2014-05-12 | -$32.84M derived: sum of 4 quarters · filed 2014-05-12 | ||
| 2013-12-31 | -$8.63M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$15.04M derived: sum of 2 quarters · filed 2014-03-17 | -$22.49M derived: sum of 3 quarters · filed 2014-03-17 | -$29.51M 10-K · filed 2014-03-17 | ||
| 2013-09-30 | -$6.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$13.86M derived: sum of 2 quarters · filed 2013-11-12 | -$20.88M 10-Q · filed 2013-11-12 | -$25.88M derived: sum of 4 quarters · filed 2014-05-12 | ||
| 2013-06-30 | -$7.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$14.47M 10-Q · filed 2013-08-09 | -$19.46M derived: sum of 3 quarters · filed 2014-05-12 | -$24.47M derived: sum of 4 quarters · filed 2014-05-12 | ||
| 2013-03-31 | -$7.02M 10-Q · filed 2014-05-12 | -$12.02M derived: sum of 2 quarters · filed 2014-05-12 | -$17.03M derived: sum of 3 quarters · filed 2014-05-12 | -$20.98M derived: sum of 4 quarters · filed 2014-05-12 | ||
| 2012-12-31 | -$5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$10.00M derived: sum of 2 quarters · filed 2014-03-17 | -$13.96M derived: sum of 3 quarters · filed 2014-03-17 | -$19.68M 10-K · filed 2014-03-17 | ||
| 2012-09-30 | -$5.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$8.97M derived: sum of 2 quarters · filed 2013-11-12 | -$14.68M 10-Q · filed 2013-11-12 | -$18.53M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-06-30 | -$3.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$9.67M 10-Q · filed 2013-08-09 | -$13.52M derived: sum of 3 quarters · filed 2014-03-17 | -$17.12M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-03-31 | -$5.72M 10-Q · filed 2013-05-10 | -$9.56M derived: sum of 2 quarters · filed 2014-03-17 | -$13.16M derived: sum of 3 quarters · filed 2014-03-17 | -$15.95M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2011-12-31 | -$3.85M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$7.44M derived: sum of 2 quarters · filed 2014-03-17 | -$10.24M derived: sum of 3 quarters · filed 2014-03-17 | -$13.59M 10-K · filed 2014-03-17 | ||
| 2011-09-30 | -$3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$6.39M derived: sum of 2 quarters · filed 2012-11-09 | -$9.75M 10-Q · filed 2012-11-09 | -$10.00M 10-Q · filed 2011-11-08 | -$12.53M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-06-30 | -$2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$6.15M 10-Q · filed 2012-08-09 | -$6.40M 10-Q · filed 2011-08-09 | -$8.93M derived: sum of 3 quarters · filed 2013-03-18 | -$10.92M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-03-31 | -$3.36M 10-Q · filed 2012-05-10 | -$6.13M derived: sum of 2 quarters · filed 2013-03-18 | -$8.13M derived: sum of 3 quarters · filed 2013-03-18 | |||
| 2010-12-31 | -$2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$4.77M derived: sum of 2 quarters · filed 2013-03-18 | -$7.73M 10-K · filed 2013-03-18 | |||
| 2010-09-30 | -$1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$4.96M 10-Q · filed 2011-11-08 | ||||
| 2010-06-30 | -$2.96M 10-Q · filed 2011-08-09 | |||||
| 2009-12-31 | -$4.26M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |